Editorial,  Res J Econ Vol: 8 Issue: 6

Gender Economics Analysis: Understanding Inequality and Economic Outcomes

Dr. Maria S. Duarte^*

Department of Gender Studies, Lisbon School of Economics, Portugal

*Corresponding Author:

Dr. Maria S. Duarte
Department of Gender Studies, Lisbon School of Economics, Portugal
E-mail: m.duarte@lse.pt

Received: 01-Nov-2025, Manuscript No. rje-26-184077; Editor assigned: 4-Nov-2025, Pre-QC No. rje-26-184077 (PQ); Reviewed: 19-Nov-2025, QC No. rje-26-184077; Revised: 26-Nov-2025, Manuscript No. rje-26-184077 (R); Published: 30-Nov-2025, DOI: 10.4172/rje.1000208

Citation: Maria SD (2025) Gender Economics Analysis: Understanding Inequality and Economic Outcomes. Res J Econ 8: 208

Introduction

Gender economics analysis examines how economic outcomes differ between men and women and how social norms, institutions, and policies shape these differences. Despite progress in education and labor force participation, gender gaps persist in wages, employment, wealth, and access to economic opportunities across many countries. Gender economics provides a framework for understanding these disparities and for designing policies that promote equality, efficiency, and inclusive growth [1,2].

Discussion

One of the central topics in gender economics is the gender wage gap. On average, women earn less than men, even after accounting for education and experience. This gap reflects a combination of factors, including occupational segregation, differences in working hours, career interruptions related to caregiving, and discrimination. Women are more likely to be concentrated in lower-paying sectors and underrepresented in senior and leadership positions, limiting lifetime earnings and wealth accumulation [3,4].

Labor market participation is another key area of gender economics analysis. Women often face barriers to entering and remaining in the workforce, such as limited access to childcare, inflexible work arrangements, and unequal household responsibilities. Unpaid care work, which is disproportionately carried out by women, has significant economic value but is largely excluded from traditional economic measures. Gender economics highlights how recognizing and redistributing care work can improve both gender equality and economic productivity [5].

Gender differences also appear in access to resources and financial markets. In many regions, women have less access to credit, land ownership, and financial services, constraining entrepreneurship and investment. Closing these gaps can generate substantial economic gains by enabling more efficient allocation of talent and capital.

Public policy plays a critical role in shaping gender outcomes. Policies such as parental leave, affordable childcare, equal pay legislation, and anti-discrimination laws can reduce gender disparities in labor markets. Education and health investments targeted at girls and women have strong intergenerational effects, improving human capital and long-term growth.

Conclusion

Gender economics analysis demonstrates that gender inequality is not only a social issue but also an economic one. Persistent gender gaps reduce efficiency, limit growth, and exacerbate inequality. By applying gender-sensitive economic analysis, policymakers can design interventions that promote fairness while enhancing overall economic performance. Advancing gender equality is therefore central to building more inclusive and resilient economies.

References

1. Craigle V (2007) MedWatch: The FDA safety information and adverse event reporting program. Journal of the Medical Library Association 95:224.

   Indexed at, Google Scholar

2. Pacurariu AC, Coloma PM, van Haren A, Genov G, Sturkenboom MC, et al. (2014) A description of signals during the first 18 months of the EMA pharmacovigilance risk assessment committee. Drug safety 37:1059-1066.

   Indexed at, Google Scholar

3. Lawrence Gould A (2003) Practical Pharmacovigilance analysis strategies. Pharmacoepidemiology and drug safety 12:559-574.

   Indexed at, Google Scholar, CrossRef

4. Tandon V, Mahajan V, Khajuria V, Gillani Z (2015) Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India. Indian J Pharmacol 47:65-71.

   Indexed at, Google Scholar, CrossRef

5. Khattri S, Balamuralidhara V, Pramod KTM, Valluru R, Venkatesh MP, et al. (2012) Pharmacovigilance regulations in India: a step forward. Clin Res Regul Aff 29:41-45.

   Google Scholar, CrossRef